Opinion|Videos|January 7, 2026
Closing Thoughts from the Experts
This final segment consists of expert clinicians offering key takeaways to help pharmacists prepare for potential approvals and integrate new TNBC therapies into practice.
Advertisement
Episodes in this series
An expert pharmacist and physician offer their main takeaways from the recent clinical trial data in TNBC. Clinical pearls for pharmacists are offered that will help prepare them for potential approval of these pharmacotherapies.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Related Content
Advertisement
Latest CME
Trending on Pharmacy Times
1
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
2
SGLT2 Inhibitors in T2D Lower 5-Year Risk of CKD and Acute Kidney Injury
3
Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment
4
Q&A: How Pharmacists Can Address Structural Barriers in Obesity Care
5